Clinical Trials Directory

Trials / Completed

CompletedNCT04608253

A Retrospective Analysis of the Diagnostic Performance of 11C-choline PET/CT in Primary Hyperparathyroidism

A Retrospective Analysis of the Diagnostic Performance of 11C-choline PET/CT for Detection of Hyperfunctioning Parathyroid Glands After Prior Negative or Discordant Imaging in Primary Hyperparathyroidism

Status
Completed
Phase
Study type
Observational
Enrollment
36 (actual)
Sponsor
University Medical Center Groningen · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The leading cause of primary hyperparathyroidism (pHPT) is a solitary adenoma (89%). The treatment of pHPT is generally surgical removal of the overactive parathyroid gland(s). Since a solitary adenoma is the predominant cause, parathyroid surgery is preferably performed through a minimally invasive parathyroidectomy (MIP) in which only the suspected adenoma causing the pHPT is resected in a focused manner. To facilitate the performance of a MIP, accurate preoperative imaging is pivotal. This study aimed to analyze the diagnostic performance of 11C-choline PET/CT after prior negative or discordant first-line imaging in patients with pHPT undergoing parathyroid surgery with an optimized imaging protocol.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TEST11C-choline PET/CT11C-choline PET/CT

Timeline

Start date
2015-01-01
Primary completion
2019-12-31
Completion
2020-08-01
First posted
2020-10-29
Last updated
2024-04-16

Source: ClinicalTrials.gov record NCT04608253. Inclusion in this directory is not an endorsement.